Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for SANUWAVE Health (SNWV) over the last 9 years, with Q3 2025 value amounting to $4.5 million.

  • SANUWAVE Health's Cash from Investing Activities rose 942291.67% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 388961.04%. This contributed to the annual value of -$490000.0 for FY2024, which is 243333.33% down from last year.
  • According to the latest figures from Q3 2025, SANUWAVE Health's Cash from Investing Activities is $4.5 million, which was up 942291.67% from -$1.2 million recorded in Q2 2025.
  • Over the past 5 years, SANUWAVE Health's Cash from Investing Activities peaked at $4.5 million during Q3 2025, and registered a low of -$1.2 million during Q2 2025.
  • Over the past 3 years, SANUWAVE Health's median Cash from Investing Activities value was -$92000.0 (recorded in 2024), while the average stood at $244090.9.
  • Over the last 5 years, SANUWAVE Health's Cash from Investing Activities had its largest YoY gain of 942291.67% in 2025, and its largest YoY loss of 115978.26% in 2025.
  • Over the past 3 years, SANUWAVE Health's Cash from Investing Activities (Quarter) stood at $177000.0 in 2023, then plummeted by 233.33% to -$236000.0 in 2024, then surged by 1996.19% to $4.5 million in 2025.
  • Its Cash from Investing Activities stands at $4.5 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$162000.0 for Q1 2025.